You are here

Eli Lilly

Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact

Benzinga

Thu, 05/15/25 - 10:40 pm

RNA therapeutics

J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus

Fierce Biotech

Tue, 05/13/25 - 11:10 am

Stylus Medicine

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial

Investing.com

Sun, 05/11/25 - 10:06 pm

clinical trials

US judge sides with FDA's removal of Lilly's weight loss drug from shortage list

MSN/Reuters

Wed, 05/7/25 - 11:05 pm

Are pharma’s DTC platforms actually creating engagement with patients?

Medical Marketing and Media

Tue, 05/6/25 - 10:27 am

patient engagement

Lilly forges a $415m ALS alliance with UK biotech Alchemab

Pharmaphorum

Tue, 05/6/25 - 10:15 am

Alchemab Therapeutics

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool

Sun, 05/4/25 - 12:09 pm

Viking Therapeutics

WHO set to back use of weight-loss drugs for adults globally, raises cost issue

MSN/Reuters

Thu, 05/1/25 - 10:28 pm

Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance

Yahoo Finance

Thu, 05/1/25 - 11:00 am

Zealand Pharma Hires Lilly Executive as Biotech Ramps Up in Obesity

MSN/Reuters

Wed, 04/23/25 - 10:27 pm

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

CNBC

Wed, 04/23/25 - 11:01 am

compounded drugs

Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts

Fierce Pharma

Thu, 04/17/25 - 11:06 pm

BMO Capital Markets

Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s

Yahoo/Bloomberg

Thu, 04/17/25 - 11:34 am

clinical trials

BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics

Yahoo Finance

Thu, 04/17/25 - 11:28 am

BigHat Biosciences

artificial intelligence

machine learning

Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data

Clinical Trials Arena

Tue, 04/15/25 - 11:11 am

Verve Therapeutics

Five Biggest Drug Face-Offs in Pharma History

BioSpace

Wed, 04/9/25 - 11:38 am

Bristol Myers Squibb

HHS leaves door open to future Medicare coverage of obesity drugs

BioSpace

Tue, 04/8/25 - 11:54 am

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

CNBC

Sun, 04/6/25 - 11:40 pm

The top 10 pharma R&D budgets for 2024

Fierce Biotech

Fri, 04/4/25 - 11:30 am

Bristol Myers Squibb

Eli Lilly helps struggling Sangamo with $1.4B gene therapy deal

Fierce Biotech

Thu, 04/3/25 - 10:14 pm

Sangamo Therapeutics

Pages